Bacterial Infections: all 665 studies

Page 3 of 7. Open to participants first (99), then studies with results posted, then the rest; newest registration first within each.

• Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in SepsisCompletedNCT06991686
• The Association of Gene Polymorphisms With Invasive Bacterial Infections in Neonates and Young InfantsCompletedNCT06985160Not applicable
• Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TAActive, not recruitingNCT06838780
• Molecular Panel Evaluation for Diagnosis of Infections of the Central Nervosous SystemCompletedNCT06720519
• Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)CompletedNCT06709521Phase 4
• Microbiome Analysis of Dental Biofilm on High-Density Polytetrafluoroethylene Membranes Used in Socket PreservationCompletedNCT06694844Not applicable
• A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant WomenActive, not recruitingNCT06592586Phase 2/3
• Microorganisms on Reusable TourniquetsActive, not recruitingNCT06566495
• Development and Validation of (Bio)Sensors for the Identification of PathogensCompletedNCT06548841
• A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult ParticipantsCompletedNCT06547554Phase 1
• Bloodstream Infection of Carbapenem-Resistant Proteus MirabilisCompletedNCT06542965
• The Oxford Pleural Infection Endotyping StudyCompletedNCT06513689
• Prospective Study on Febrile Batteries in Pediatric Oncohaematological Patients (SuBiTo)Active, not recruitingNCT06419426
• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation SuspensionTerminatedNCT06418711Phase 3
• Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric CohortsCompletedNCT06379061
• Antibiotics Resistance Gene in Healthcare WorkersCompletedNCT06228248
• An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream InfectionsCompletedNCT06211829
• Clinical Outcomes of Hypervirulent Carbapenem-resistant Klebsiella Pneumoniae InfectionCompletedNCT06190548
• Evaluation of the Artificial Intelligence-based Prescription Support Software iAST® for the Choice of Empirical and Semi-targeted Antibiotic TreatmentCompletedNCT06174519
• PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal ImpairmentCompletedNCT06157242Phase 1
• Smartphone App-assisted Short-term Antibiotic TherapyCompletedNCT06126900Not applicable
• Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal InfectionsActive, not recruitingNCT06126263
• Integrated Clinical Decision Support for Empiric Antibiotic Selection in SepsisTerminatedNCT06103500Not applicable
• Hydrogen Peroxide Fumigation in Dental Office EnvironmentCompletedNCT06100848Not applicable
• Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)Active, not recruitingNCT06093269Phase 4
• P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy ParticipantsCompletedNCT06079775Phase 1
• Monolaurin Ointment Versus Mupirocin OintmentCompletedNCT06046937Early Phase 1
• Clinical Evaluation of the AP203 Plant Extract Mixture in Adult Patients With Increased Incidence of Viral and/or Bacterial Upper Respiratory Tract InfectionsCompletedNCT06020001Not applicable
• VAT-2: Evaluation of a Virtual Antimicrobial Stewardship Team (VAT) on Antibiotic Prescriptions in Nursing HomesCompletedNCT05998226Not applicable
• Therapeutic Drug Monitoring - Targeting IMproved EffectivenessCompletedNCT05971979
• A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver CirrhosisCompletedNCT05960006
• Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)CompletedNCT05950984
• The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult VolunteersTerminatedNCT05942820Phase 1
• TDM-optimized Teicoplanin Dosing Versus Standard of CareTerminatedNCT05914467Phase 4
• Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDROCompletedNCT05897801
• Challenge Non-Typhoidal Salmonella (CHANTS) StudyActive, not recruitingNCT05870150Not applicable
• Effect of Bifidobacterium Breve PRL2020 (an Amoxicillin-clavulanate-resistant Strain) on Gastrointestinal Symptoms and Gut Microbiota Composition in Children Treated With Amoxicillin or Amoxicillin/ClavulanateCompletedNCT05840588Not applicable
• A Retrospective Study on Personalized Dosing Strategy of Patients Treated by Carbapenems: 2018-2021Status unknownNCT05762094
• TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New EraCompletedNCT05752019
• Diagnostic Evaluation Study of the BactInsight Blood Culture System in West-AfricaCompletedNCT05722184
• Exploratory Study of Respiratory Bacterial Infections or Superinfections and Colonizations in Patients With Spinal Muscular Atrophy Under NIVCompletedNCT05712330Not applicable
• MeMed BV® Test Evaluation in Adult Emergency Department PatientsCompletedNCT05706935
• Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled TrialCompletedNCT05689229Phase 3
• How to Reduce Unnecessary Blood Cultures: Construction and Validation of a Predictive Score for Blood Culture Positivity in Intensive CareCompletedNCT05686577
• To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100CompletedNCT05684718Phase 1
• Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100CompletedNCT05684705Phase 1
• Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI)CompletedNCT05667207Not applicable
• Prediction of Multidrug-resistant Bacterial Infection in Patients with CirrhosisCompletedNCT05641025
• Evaluation of the Antibacterial Effect of a Toothpaste Containing Zinc LactateStatus unknownNCT05628571Phase 3
• A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial InfectionsCompletedNCT05614895Phase 1
• Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic AcidCompletedNCT05611905
• Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy WomenStatus unknownNCT05587283Phase 1
• Pharmacokinetics of Colistin in Critically-ill Patients With AKI Who Receive SLEDCompletedNCT05586438Phase 4
• Clinical Performance of the AtbFinder® Test System for Selection of Antibiotic Therapy in Persons With Cystic FibrosisCompletedNCT05584982Not applicable
• A Pharmacokinetic Study of LP-001 in Children With a Bacterial InfectionCompletedNCT05584683Phase 1
• Association of Cephalosporin Resistance and Surgical Site Infections in Patients Undergoing PancreaticoduodenectomyCompletedNCT05581017
• Bacteriophage Therapy of Difficult-to-treat InfectionsCompletedNCT05498363
• PLGA Nanoparticles Entrapping Ciprofloxacin to Treat E-Fecalis Infections in EndodonticsCompletedNCT05475444Not applicable
• Evaluation of Gel and Solution of Chlorhexidine in Disinfection Root Canals of Primary Anterior Teeth.CompletedNCT05361278Not applicable
• Metagenomic Sequencing in Clinical Infectious DiseasesCompletedNCT05353634
• A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRSWithdrawnNCT05340257Phase 2
• High Calorie Formula Intervention on Weight, Length Increment, Total Lymphocyte Counts, TNF-alpha and IGF-1 in Failure to Thrive ChildrenCompletedNCT05333133Not applicable
• A First-in-Human Study With XAB05 in Healthy SubjectsCompletedNCT05307406Phase 1
• Retrospective Chart Review of Treataprost Added to Antibiotic Treatment in Patients With Chronic ProstatitisStatus unknownNCT05306314
• Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19CompletedNCT05293418
• Phenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseudomonas Aeruginosa Isolates From Brazilian Hospitals: Implications for the Introduction of IMIPENEM-RELEBACTAMStatus unknownNCT05285046
• Bacteriophage Therapy in First Time Chronic Prosthetic Joint InfectionsWithdrawnNCT05269121Phase 1/2
• S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract InfectionsCompletedNCT05261152Phase 4
• Febrile Infant Diagnostic Assessment and Outcome StudyCompletedNCT05259683
• Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy SubjectsCompletedNCT05226923Phase 1
• Drug Use Evaluation of Clindamycin in Critical Care Units in Alexandria Main University HospitalCompletedNCT05223400
• RBG: Regular, Bare, Gel: Does Type of Nail Polish Affect Bacterial Counts After Surgical Scrubbing?CompletedNCT05210920Not applicable
• Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli InfectionsTerminatedNCT05210387Not applicable
• Target Attainment of CefuroximStatus unknownNCT05200975Not applicable
• ElastoMeric Infusion Pumps for Hospital AntibioTICsCompletedNCT05150015Not applicable
• Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.Active, not recruitingNCT05123755Phase 2
• Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern JordanCompletedNCT05106803
• Effect of Passive Ultrasonic Irrigation on Bacteria That Persist After Root Canal PreparationCompletedNCT05100433Not applicable
• A Natural History Study to Assess the Clinical Outcomes of Patients With Complement Factor I Deficiency-Mediated DiseaseTerminatedNCT05095623
• Micro-hematology Analyzer for Viral/Bacterial DescriptionStatus unknownNCT05090319
• A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy VolunteersCompletedNCT05088421Phase 1
• Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult SubjectsCompletedNCT05072444Phase 1
• Complications After Lower Third Molar SurgeryStatus unknownNCT05027893Not applicable
• Spectrum of Bacterial Infections in RheumatologyCompletedNCT05007405
• The Clinical Character，Risk and Prognosis of Post-neurosurgical Intracranial Infection With Different Pathogens.Status unknownNCT04917380
• Clinical Decision Support Tool for Vancomycin Dosing in ChildrenCompletedNCT04911270Not applicable
• ICIS in Burn Patients Compared to Other Inflammatory MarkersCompletedNCT04894500
• Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing.Status unknownNCT04864873Not applicable
• Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient TransitionTerminatedNCT04847921Phase 2/3
• Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)CompletedNCT04841369Phase 3
• Host RNA Profiles to Detect Infections in Young InfantsCompletedNCT04823026
• T2 and SeptiCyte RAPID Duration ProjectCompletedNCT04821661
• Antibiotics Continuous Infusion at HomeStatus unknownNCT04816968Phase 1
• SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy VolunteersCompletedNCT04808414Phase 1
• Frequence of Dressing Change and Bacterial Colonization in Pediatric Intensive Care UnitCompletedNCT04806776Not applicable
• Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy SubjectsCompletedNCT04802863Phase 1
• To Evaluate the Pharmacokinetics of XNW4107 in Healthy Adult Young Females and in Healthy Adult Elderly Males and Females.CompletedNCT04801043Phase 1
• Comparison of Sterile Gauze and Semi-permeable Film Dressing for Hemodialysis Central Venous CatheterStatus unknownNCT04800575Not applicable
• Pharmacokinetics of XNW4107 in Subjects With Various Degrees of Renal FunctionCompletedNCT04787562Phase 1
• Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE InfectionsWithdrawnNCT04785924Phase 4

← Bacterial Infections overview